KR101970646B1 - Microfluidic device, and treating method of single-cell using the same - Google Patents
Microfluidic device, and treating method of single-cell using the same Download PDFInfo
- Publication number
- KR101970646B1 KR101970646B1 KR1020160028958A KR20160028958A KR101970646B1 KR 101970646 B1 KR101970646 B1 KR 101970646B1 KR 1020160028958 A KR1020160028958 A KR 1020160028958A KR 20160028958 A KR20160028958 A KR 20160028958A KR 101970646 B1 KR101970646 B1 KR 101970646B1
- Authority
- KR
- South Korea
- Prior art keywords
- well
- single cell
- solution
- sample
- microfluidic device
- Prior art date
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0819—Microarrays; Biochips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
Abstract
A sample liquid containing a single cell as a target cell or a first well containing a reagent, a second well disposed apart from the first well, and a second well extending from a lower surface of the first well to a lower surface of the second well, A microfluidic device including at least two microfluidic channels connecting a first well and a second well, wherein a width of the microfluidic channel is smaller than that of a single cell, and a single cell treatment method using the microfluidic device.
Description
A microfluidic device, and a method for treating a single cell using the same.
Cancer is currently the leading cause of morbidity and mortality worldwide, not only in Korea. The greatest impact on the mortality rate of cancer patients depends on the presence or absence of metastatic cancer cells. In other words, the technique of accurately and accurately detecting single cells such as circulating tumor cells (CTC), which is present in one of the blood cell's hundreds of millions of blood cells, improves the survival rate before and after cancer treatment It is essential.
For example, in the case of breast cancer, blood should be found at less than 5 in 7.5 ml, less than 3 in colorectal cancer, and less than 5 in prostate cancer, and the throughput, Micro cells that meet three basic conditions such as cell count, recovery (ratio of single cell count to the number of single cells injected / collected), and collection efficiency (purity, purity of separated single cells) Cell separation technology is required.
CTC capture methods that have been published so far include gene detection using polymerase chain reaction (PCR), centrifugation, meter reading using magnetophoresis, and fluorescence staining or using a filter.
However, in the conventional methods, a single cell may be lost through a process of removing a large number of blood cells contained in blood for CTC detection. In addition, there is a possibility that a single cell may be lost in the course of performing a treatment such as dyeing by injecting a single cell from which the hemocyte has been removed into a separate experimental device.
One embodiment provides a microfluidic device capable of minimizing the loss of single cells during various processing steps of a single cell.
In addition, a single cell treatment method capable of continuously treating single cells through a microfluidic device according to an embodiment is provided.
According to one embodiment, a sample liquid containing a single cell as a target cell, or a first well containing a reagent, a second well disposed apart from the first well, and a second well from the lower surface of the first well, The microfluidic device is provided with two or more microfluidic channels extending to the lower surface of the well and connecting the first well to the second well, wherein the width of the microfluidic channel is smaller than the size of the single cell.
The ratio of the area of the lower surface of the first well to the cross-sectional area in the width direction of the micro channel may be 1000: 1 to 400000000: 1.
The micro flow path may further include a first reservoir portion formed between the at least two micro flow paths and the second well, and the at least two micro flow paths and the second well may be connected to the first reservoir portion, respectively.
The at least two micro flow paths may connect the first well and the second well in parallel.
The width of the fine flow path may be 0.5 탆 to 15 탆.
The lower surface of the first well and the lower surface of the second well may be coplanar.
The lower surface of the first well viewed from above may have a circular shape.
The lower surface diameter of the first well may be between 1 mm and 50 mm.
The microfluidic device may include two or more single cell processing units each including the first well, the second well, and the two or more microchannels.
The two or more single cell processing units may be arranged to have a matrix form.
According to another aspect of the present invention, there is provided a method of treating a single cell using the microfluidic device, comprising: injecting a sample solution containing a single cell into the first well; injecting a fixer into the first well, Treating the fixed single cells by injecting a permeate into the first well, and injecting a staining solution into the first well to stain the pre-treated single cells. / RTI >
A negative force may be applied to the second well to remove the sample solution, the fixation solution, the penetration solution, and the staining solution from the first well.
The sample solution, fixer solution, permeate solution, and dye solution removed from the first well may be passed through the micro channel to be accommodated in the second well.
The flow rate of the sample solution, fixing solution, permeation solution, and dyeing solution passing through the microchannel by the applied negative pressure may be larger than the movement speed of the single cell induced by the negative pressure.
The single cell processing method may further include washing the first well by injecting a washing solution into the first well.
Upon completion of the washing step, a negative force may be applied to the second well to remove the washing liquid from the first well.
It is possible to provide a microfluidic device capable of minimizing the loss of single cells during various processes of single cells.
In addition, it is possible to provide a single cell treatment method capable of continuously treating single cells through a microfluidic device.
1 is a perspective view illustrating a microfluidic device according to an embodiment,
FIG. 2 is a top plan view of the microfluidic device of FIG. 1,
3 is a cross-sectional view taken along line III-III in Fig. 2,
4 to 6 show various modifications of the single cell processing unit according to one embodiment,
7 is an image showing a microfluidic device including two or more single cell processing units according to another embodiment,
FIGS. 8 to 18 are views sequentially illustrating a single cell processing method according to one embodiment,
19 is a fluorescence microscope image showing single cells stained according to one embodiment.
Hereinafter, exemplary embodiments will be described in detail so that those skilled in the art can easily carry out the present invention. However, the present invention can be implemented in various different forms and is not limited to the embodiments described herein.
In the drawings, the thickness is enlarged to clearly represent the layers and regions. Like parts are designated with like reference numerals throughout the specification. Whenever a portion of a layer, film, region, plate, or the like is referred to as being "on" another portion, it includes not only the case where it is "directly on" another portion, but also the case where there is another portion in between. Conversely, when a part is "directly over" another part, it means that there is no other part in the middle.
A " single-cell ", which in one embodiment is a target cell, is a very rare cell in which only a few to a few tens of cells are present, for example, And circulating tumor cells (CTC), which are present in one of hundred million blood cells.
In one embodiment, the term " reagent " refers to various kinds of drugs for biochemical treatment of the single cell. For example, the reagent means a washing solution such as a buffer solution, a fixing solution, a permeator, to be.
On the other hand, in one embodiment, the "sample liquid" means that the "single cell" is contained in a reagent such as a buffer solution or the like.
First, a schematic structure of a microfluidic device according to an embodiment will be described with reference to FIGS. 1 and 2. FIG.
FIG. 1 is a perspective view illustrating a microfluidic device according to one embodiment, and FIG. 2 is a plan view of the microfluidic device of FIG. 1 viewed from above.
1 and 2, a
In one embodiment, the
The single
The
Meanwhile, the
However, the present invention is not limited to this embodiment, and it may be formed of a material having hydrophilic property, and at least a surface of the
The
The
As shown in FIG. 2, the first and
The
On the other hand, two or more
The
In one embodiment, the width of
Since the
That is, in the
More specifically, a sample liquid or reagent contained in the
The hydraulic resistance applied to the
............................................ (Equation 1)
In Equation 1, R h denotes a hydraulic resistance applied to the
In one embodiment, by applying a negative pressure greater than the product of the hydraulic resistance of the
If a pressure capable of overcoming the hydraulic resistance of the micro channel 24 (for example, negative pressure equal to or higher than a critical pressure due to the hydraulic resistance of the micro channel 24) is supplied to the
Accordingly, in the
Hereinafter, the structure of the single
3 is a sectional view taken along the line III-III in FIG.
3, the
When the width of the
The cross section in the width direction of the
On the other hand, the length of the
When the length of the
The heights of the
The lower surface of the
3, the lower surface diameter D1 of the
The diameter D1 of the lower surface of the
In one embodiment, when the sample solution is injected into the
This is because as negative pressure is applied to the
That is, when negative pressure is applied to the
The behavior of such single cells within the
The ratio of the area of the lower surface of the
By adjusting the ratio of the area of the lower surface of the
In a process for removing only a specific fluid from a general microfluidic device, valves formed in a microfluidic channel are used, or a multiplexed pump device is used. Such a typical microfluidic device has the troubles of precision control of the valves or connection of a fluidic adapter or a syringe pump every time a specific fluid removal process is performed.
As another method for concentrating single cells, when a microfluidic device is centrifuged, loss of single cells may occur during aspiration of a sample solution or a reagent after centrifugation.
In addition, even when the single cells obtained through the above method are smeared on the substrate and then the subsequent treatment is performed, loss of single cells may occur in the process of washing, etc., and then the single cells are recovered and further processed (For example, when DNA must be extracted after recovery of a single cell line), single cell loss may occur during recovery.
However, in the case of the
Accordingly, the
That is, according to one embodiment, it is possible to continuously perform a single cell treatment process in the
Hereinafter, various modifications of the single cell processing unit according to one embodiment will be described with reference to FIGS. 4 to 6. FIG.
Referring to FIG. 4, the single cell processing unit may be arranged such that two or more microchannel 24 'are connected in parallel to the
4, the fine flow path 24 'has a structure in which five flow paths are arranged in parallel to each other in parallel, but the present invention is not limited thereto. The size of the hydraulic pressure resistance varies depending on the number of the fine flow paths 24' The diameter and the cross-sectional area of the
5, the single-cell processing unit may further include a
5, the length of the
6, the single-cell processing unit may further include a
5, the
As described above, even if the
Hereinafter, a microfluidic device according to another embodiment will be described with reference to FIG.
7 is an image showing a microfluidic device including two or more single cell processing units according to another embodiment.
Referring to FIG. 7, the
That is, since no separate flow path is formed between neighboring single
The
As described above, the
Hereinafter, a single cell processing method using a microfluidic device according to one embodiment will be sequentially described with reference to FIGS. 8 to 18. FIG.
The single cell treatment method according to an embodiment includes injecting a sample solution containing a single cell into the
First, as shown in Fig. 8, a
9, when a negative pressure equal to or higher than the critical pressure due to the hydraulic pressure resistance of the
The length of the microchannel 24 in the width direction is smaller than the size of the
On the other hand, even after the removal of the
Meanwhile, in one embodiment, the cleaning step may further include washing the
11, when the cleaning
As a result, when washing of the sample solution is completed, only a small amount of the
Thereafter, in the fixing step, fixing
Thereafter, the cleaning process as shown in FIG. 11 is performed once to clean the inside of the
15, the infiltrating
Thereafter, the cleaning process as shown in FIG. 11 is performed once to clean the inside of the
17, the
Thereafter, the cleaning process as shown in FIG. 11 is performed once to clean the inside of the
As described above, even when the sample is injected into the
That is, one embodiment can provide a single cell treatment method capable of continuously treating a
Hereinafter, specific embodiments of the present invention will be described. The embodiments described below are only intended to illustrate or explain the present invention, and thus the present invention should not be limited thereto. In addition, contents not described here can be inferred sufficiently technically if they are skilled in the art, and a description thereof will be omitted.
Fabrication of microfluidic devices
A predetermined groove pattern is formed on the surface of a PDMS (manufactured by Dow Corning) substrate having a width of 75 mm, a length of 25 mm and a thickness of 5 mm by using a soft lithography method. The depth of the formed groove pattern may be 10 [mu] m and the line width may be 6 [mu] m.
Thereafter, the PDMS substrate is punched to form a first opening portion and a second opening portion that open the PDMS substrate in the up and down direction. The first opening and the second opening may have a circular cross-sectional shape, the cross-sectional diameter of the first opening may be 4 mm, and the cross-sectional diameter of the second opening may be 0.3 mm. The first opening portion and the second opening portion formed are connected to the groove pattern, respectively.
Thereafter, a slide glass is attached to the upper surface of the PDMS substrate having the groove pattern formed thereon, and then the PDMS substrate having the slide glass attached thereto is reversed upside down to produce a microfluidic device as shown in Fig.
The manufactured microfluidic device has a space formed by the first opening and the slide glass forming the first well, a space formed by the second opening and the slide glass forming the second well, and a space formed by the groove and the slide glass forming the microfluidic channel .
Evaluation 1: Immunocytochemistry ( immunocy tochemistry ) For single cell treatment
Prepare a sample solution in which MCF7 (breast cancer cells) is dispersed in phosphate buffered saline (PBS) as a single cell. MCF7 is based on the sample solution of about 30 μ L can contain from about 10 to about 20.
30 μL of the prepared sample solution was injected into the first well of the prepared microfluidic device, and then the pipette was placed in the second well. The negative pressure was applied to the sample, and the PBS was pipetted at a flow rate of about 100 μL / min or less Lt; / RTI >
Then, 20 μL of PBS was injected into the first well to wash the first well, the pipette was placed in the second well, and the PBS remaining in the first well was applied at about 100 μL / min To the pipette at the following flow rate.
Then, 20 μL of 4% paraformaldehyde (PFA) is injected into the first well as a fixative, and MCF7 is immobilized on the slide glass for 10 minutes. Thereafter, the pipette is placed in the second well and negative pressure is applied to remove the PFA remaining in the first well.
Then, 20 μL of PBS is injected into the first well to wash the first well, the pipette is placed in the second well, and negative pressure is applied to remove the remaining PBS in the first well.
Then, the injection of 0.1% saponin (saponin) of 20 μ L into chimtuaek the first well, and performs the task of penetrating the cell membrane of the chimtuaek MCF7 fixed on a slide glass over a period of 10 minutes.
Then, 20 μL of PBS is injected into the first well to wash the first well, and then the pipette is placed in the second well, and the saponin remaining in the first well is removed by applying negative pressure.
Then, the first and the Hoechst (blue), FITC (green) and PE (red), 0.1% saponin, and a
Then, 20 μL of PBS was injected into the first well to wash the first well, the pipette was placed in the second well, and negative pressure was applied to remove the remaining dye in the first well.
Thereafter, the microfluidic device containing the stained MCF7 was dried, and the stained MCF7 was observed through a fluorescence microscope. The results are shown in Fig.
19 is a fluorescence microscope image showing single cells stained according to one embodiment.
Referring to FIG. 19, it can be seen that the nucleus portion of MCF7 was blue by Hoechst, the cytokeratin portion of MCF7 was green by FITC, and the EpCAM portion of MCF7 was red by PE.
In one embodiment, the present invention is not necessarily limited to this, and the single cell may be a prostate cancer cell (PC3), a melanoma (M14), a colon cancer cell (HT29), a gastric cancer cell (HGC27, NUGC2, MKN7, MKN28) Cancer cell (OVCA433) or the like may be used. If blood such as whole blood in which hemocyte cells have not been removed from MCF7 is used as a sample fluid, in addition to the above-described treatment process, a step of dissolving and removing red blood cells And the like.
Also, as a staining agent, the cytokeratin moiety can be stained red with PE and the CD45 moiety can be stained with green using Alexa488.
As described above, by using the microfluidic device according to one embodiment, various cell processes of a single cell can be continuously performed in the microfluidic device.
Evaluation 2: Continuous reagent exchange
Approximately 10 to 40 pre-fixed MCF7 were injected into the first well of the microfluidic device using MCF7 as a single cell, 20 [ mu] L of PBS was injected into the first well, and a pipette was placed in the second well And the negative pressure is applied to remove the PBS remaining in the first well is repeated 32 times in total. The number of MCFs remaining in the first well was recorded for each repeated execution step to determine the number of times at which the MCF7 was lost. The results are shown in Table 1 below.
Referring to Table 1, it was found that MCF7 was lost in the first cell at a high probability of about 94%, and only 32 of the total 32 times were lost. Can be confirmed. That is, when the microfluidic device according to one embodiment is used, loss of a single cell can be minimized even when a repetitive cell treatment step is performed unlike a general centrifugation method or the like.
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, And falls within the scope of the invention.
2: single cell 3: sample
4: Washing solution 5: Fixing solution
6: Penetrating solution 7: Staining solution
10: substrate 20: single cell processing unit
21: body 22: first well
23: second well 24: fine flow path
25: first bottom part 26: second bottom part
100, 200: microfluidic device
Claims (16)
A second well disposed apart from the first well,
And two or more microchannels extending from a lower surface of the first well to a lower surface of the second well to connect the first well to the second well,
Wherein a diameter of a lower surface of the first well is larger than a diameter of a lower surface of the second well,
The width of the micro channel is smaller than the size of the single cell,
And the ratio of the area of the lower surface of the first well to the cross-sectional area in the width direction of the micro channel is 1000: 1 to 400000000: 1.
Further comprising a first reservoir portion formed between the at least two micro flow paths and the second well,
Wherein the at least two micro flow paths and the second well are connected to the first reservoir portion, respectively.
Wherein the at least two micro flow paths connect the first well and the second well in parallel.
And the width of the fine flow path is from 0.5 mu m to 15 mu m.
Wherein the lower surface of the first well and the lower surface of the second well are coplanar.
Wherein the lower surface of the first well viewed from above has a circular shape.
And the lower surface of the first well has a diameter of 1 mm to 50 mm.
Wherein at least two of the first wells, the second wells, and the at least two microfluidic channels include at least two single cell processing units.
Wherein the at least two single cell processing units are arranged to have a matrix form.
Injecting a sample solution containing a single cell into the first well,
Fixing the single cell by injecting fixative into the first well,
Injecting a permeate into the first well to pre-treat the fixed single cells, and
Injecting a staining solution into the first well to stain the pretreated single cells
, ≪ / RTI &
Wherein the sample liquid, the fixing liquid, the penetrating liquid, and the dyeing liquid injected into the first well are applied to the second well in a state where a negative force exceeding a hydraulic pressure resistance applied to the microchannel is applied to the first well, Lt; / RTI >
Wherein the sample solution, fixer solution, permeate solution, and dye solution each of which is removed from the first well by the applied negative pressure are received in the second well through the micro channel.
Wherein the velocity of each of the sample liquid, the fixing liquid, the penetrating liquid, and the dyeing solution passing through the micro channel by the applied negative pressure is greater than the moving velocity of the single cell induced by the negative pressure.
Further comprising injecting a wash solution into the first well to wash the first well.
Wherein the cleaning solution is removed from the first well by applying a negative pressure in excess of the hydraulic resistance applied to the microchannel to the second well.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160028958A KR101970646B1 (en) | 2016-03-10 | 2016-03-10 | Microfluidic device, and treating method of single-cell using the same |
PCT/KR2016/009420 WO2017155170A1 (en) | 2016-03-10 | 2016-08-25 | Microfluidic element and single cell treatment method using same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160028958A KR101970646B1 (en) | 2016-03-10 | 2016-03-10 | Microfluidic device, and treating method of single-cell using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170105825A KR20170105825A (en) | 2017-09-20 |
KR101970646B1 true KR101970646B1 (en) | 2019-04-19 |
Family
ID=59789907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160028958A KR101970646B1 (en) | 2016-03-10 | 2016-03-10 | Microfluidic device, and treating method of single-cell using the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101970646B1 (en) |
WO (1) | WO2017155170A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102013996B1 (en) * | 2017-12-01 | 2019-10-21 | (주) 비비비 | Product method of lab on a chip |
KR102013997B1 (en) * | 2017-12-04 | 2019-08-29 | (주) 비비비 | Lab on a chip having micro injector and product method thereof and using method thereof |
KR102556859B1 (en) | 2022-12-15 | 2023-07-20 | (주)제이에이치에너지 | System and method for diagnosing building energy |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130302828A1 (en) * | 2010-11-19 | 2013-11-14 | On-Chip Biotechnologies Co., Ltd. | Method for detecting low concentrations of specific cell from high concentrations of cell populations, and method for collecting and analyzing detected cell |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8790891B2 (en) * | 2009-03-19 | 2014-07-29 | The General Hospital Corporation | Microfluidic cell motility assay |
KR101252829B1 (en) * | 2009-10-06 | 2013-04-11 | 한국전자통신연구원 | Array apparatus for separation of single cell |
KR20130066291A (en) * | 2011-12-12 | 2013-06-20 | 삼성전자주식회사 | Collective cell counter system |
KR101911436B1 (en) * | 2011-12-13 | 2018-10-25 | 삼성전자주식회사 | Extremely high aspect ratio filter for capturing cell |
-
2016
- 2016-03-10 KR KR1020160028958A patent/KR101970646B1/en active IP Right Grant
- 2016-08-25 WO PCT/KR2016/009420 patent/WO2017155170A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130302828A1 (en) * | 2010-11-19 | 2013-11-14 | On-Chip Biotechnologies Co., Ltd. | Method for detecting low concentrations of specific cell from high concentrations of cell populations, and method for collecting and analyzing detected cell |
Also Published As
Publication number | Publication date |
---|---|
WO2017155170A1 (en) | 2017-09-14 |
KR20170105825A (en) | 2017-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180029033A1 (en) | Multilayer disposable cartridge for ferrofluid-based assays and method of use | |
US9885059B2 (en) | Ultrahigh throughput microinjection device | |
US20070102295A1 (en) | Microfabricated structures for facilitating fluid introduction into microfluidic devices | |
US8003063B2 (en) | Microfluidic devices and methods for multiple analyte detection | |
US20160107159A1 (en) | Microfluidic device and method for controlling fluid flow thereinto | |
US11911763B2 (en) | Microfluidic device and methods | |
US7935318B2 (en) | Microfluidic centrifugation systems | |
KR101970646B1 (en) | Microfluidic device, and treating method of single-cell using the same | |
CA2842359A1 (en) | Cell capture system and method of use | |
CN106471114B (en) | Collection element and sample processing kit having the same | |
JP6746619B2 (en) | Microfluidic device | |
JP6573175B2 (en) | Separation apparatus, fluid device, separation method and mixing method | |
WO2016148085A1 (en) | Microparticle separation chip, microparticle separation system in which said microparticle separation chip is used, microparticle separation method in which said microparticle separation system is used, and microparticle extraction method | |
KR20150125336A (en) | Rare cell isolation device, method of rare cell isolation and method of rare cell detection using thereof | |
WO2015156343A1 (en) | Microparticle separation chip, and microparticle separation system and microparticle separation method which employ said microparticle separation chip | |
KR101776245B1 (en) | Particle filtration device and method of particle filtration | |
EP3048163B1 (en) | Particle filtering device and particle filtering method | |
CN210510505U (en) | Siphon valve device, microfluidic structure and analysis device | |
KR102637616B1 (en) | Microfluidic devices, microfluidic systems and particle separation methods | |
KR20140142097A (en) | Method of recollecting target material | |
JP2010071857A (en) | Plasma separation device | |
WO2017066884A1 (en) | Fluidic circuits and methods for bacterial screening | |
JP5207346B2 (en) | Microfluidic chip device | |
US20150367345A1 (en) | Continuous flow centrifugal microfluidic particle concentrator, and related methods | |
WO2019163688A1 (en) | Fluid handling device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |